Stull Steven T sold $1.9M of CPAY

Stull Steven T sold 4,643 shares of CORPAY, INC. (CPAY) at an average of $410.66 ($409.34–$412.42, $1.91M total) across 6 trades over 2026-08-18 to 2026-08-19.

Original reporting
SEC EDGAR · Stull Steven T
Published Aug 20, 2026, 8:52 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 9:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CPAY
Bearish
medium confidence
Mentioned
$CPAY
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CPAYBearishLow
01

Why it matters

The director's sale reduces insider ownership, which may be interpreted by traders as a bearish cue, though the retained stake mitigates concerns.

02

Market read

A $1.9M insider sale is a modest but noteworthy event for CPAY investors.

03

What to watch

No 10b5-1 plan and the director retains a sizable holding, indicating continued confidence.

Relevance 6/10Novelty 6/10Timing: filed today

Background

Form 4 filings disclose insider transactions and are primary sources for such events.

Company-level read

Ticker impact

$CPAYBearishMedium confidence
Context

Director Steven T. Stull sold 4,643 shares for $1.9M, reducing his stake to 23,598 shares.

Expected impact

Possible modest downside of 2-4% in the next few days as the market digests the sale.

Evidence & confidence

While the sale amount is notable for a small-cap, it is a routine transaction without a 10b5-1 plan, limiting its material impact.

Market effects

Minimal impact on the broader payments sector.

Limited to U.S. investors tracking CPAY.

Low

Counterpoint

The sale could be a routine portfolio rebalancing rather than a negative signal.

Key entities

  • Steven T. Stull

    Director of Corpay, Inc. who sold shares.

  • Corpay, Inc.

    Issuer of ticker CPAY.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CPAYMed

What Corpay (CPAY) Said on Its Q3 Earnings Call

Corpay (CPAY) reported Q3 gross margin at 30.4%, up from Q2 but down annually. Cash position was CAD 50.6M. Acquired AISPECO for airborne sensors. Expects revenue synergies sooner. Plans to scale manufacturing and expand commercial/defense businesses. Corpay provides corporate payment solutions.

$CPAYMedAI 8/10

Corpay 3Q 2026: Revenue $1.38B, EPS $5.66 — 10-Q Summary

Corpay reported 3Q 2026 revenue of $1.38B, up 17.9% YoY, and net income of $378.42M, up 36.2% YoY. Growth was driven by organic spend and transaction volumes, new sales, and acquisitions. Higher operating expenses and other costs partly offset gains. Management expects liquidity to meet needs for the next 12 months.

$CPAYHighAI 8/10

Corpay (CPAY) Q3 2026 Earnings Call Transcript

Corpay (CPAY) raised Q4 2026 revenue guidance to $1.37B and cash EPS to $7.65, up 27%. Full-year 2026 revenue is expected to rise 18%, with cash EPS up over 30%. For 2027, Corpay anticipates 9-11% organic revenue growth. The company has divested noncore businesses, using proceeds for share buybacks, and plans to allocate $2B in free cash flow to acquisitions or buybacks. Corporate Payments segment growth is expected to remain in the high teens.

$CPAYMed

Corpay Q3 Earnings Call Highlights

Corpay (NYSE:CPAY) expects 9-11% organic revenue growth in 2027, with $2B in free cash flow for acquisitions or share repurchases. The company divested noncore businesses in 2026, using proceeds for buybacks. Alpha and Avid are expected to contribute over $1.40 in combined cash EPS accretion in 2026. Corpay aims to compound adjusted EPS by over 20% annually through 2029.